Evidence map›Paper›PMID 34780571›Full record

ArticlePLoS pathogens2021

The gammaherpesvirus 68 viral cyclin facilitates expression of LANA.

Brian F Niemeyer, Bridget Sanford, Joy E Gibson, Jennifer N Berger, Lauren M Oko, Eva Medina, Eric T Clambey, Linda F van Dyk

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 80% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Brian F NiemeyerImmunology and Microbiology Department, University of Colorado Denver School of Medicine, Aurora, Colorado, United States of America.
Bridget SanfordDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
Joy E GibsonDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States of America.ORCID 0000-0003-3976-2320
Jennifer N BergerImmunology and Microbiology Department, University of Colorado Denver School of Medicine, Aurora, Colorado, United States of America.ORCID 0000-0002-7546-2758
Lauren M OkoImmunology and Microbiology Department, University of Colorado Denver School of Medicine, Aurora, Colorado, United States of America.ORCID 0000-0002-7125-7036
Eva MedinaImmunology and Microbiology Department, University of Colorado Denver School of Medicine, Aurora, Colorado, United States of America.ORCID 0000-0001-6899-0213
Eric T ClambeyDepartment of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.ORCID 0000-0002-7972-9544
Linda F van DykImmunology and Microbiology Department, University of Colorado Denver School of Medicine, Aurora, Colorado, United States of America.
University of Colorado Denver · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Molecular Pathogenesis of Infectious DiseasesT32AI052066 · NIAID · UNIVERSITY OF COLORADO DENVER · PI VAN DYK, LINDA F. · 2002 to 2022
$2.3M
Cyclin requirements in gammaherpesvirus infection and diseaseR01CA168558 · NCI · UNIVERSITY OF COLORADO DENVER · PI VAN DYK, LINDA F. · 2012 to 2016
$1.5M
In Vivo Analysis of Viral CyclinR01CA103632 · NCI · UNIVERSITY OF COLORADO DENVER · PI VAN DYK, LINDA F. · 2004 to 2008
$1.4M
Single cell analysis of virus and host gene expression in gammaherpesvirus infectionR21AI134084 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CLAMBEY, ERIC T, VAN DYK, LINDA F. · 2017 to 2018
$428k
NCI NIH HHS R01 CA103632NCI NIH HHS R01 CA168558NIAID NIH HHS R21 AI134084NIAID NIH HHS T32 AI052066
6 · The paper itself

Abstract

Gammaherpesviruses establish life-long infections within their host and have been shown to be the causative agents of devastating malignancies. Chronic infection within the host is mediated through cycles of transcriptionally quiescent stages of latency with periods of reactivation into detectable lytic and productive infection. The mechanisms that regulate reactivation from latency remain poorly understood. Previously, we defined a critical role for the viral cyclin in promoting reactivation from latency. Disruption of the viral cyclin had no impact on the frequency of cells containing viral genome during latency, yet it remains unclear whether the viral cyclin influences latently infected cells in a qualitative manner. To define the impact of the viral cyclin on properties of latent infection, we utilized a viral cyclin deficient variant expressing a LANA-beta-lactamase fusion protein (LANA::βla), to enumerate both the cellular distribution and frequency of LANA gene expression. Disruption of the viral cyclin did not affect the cellular distribution of latently infected cells, but did result in a significant decrease in the frequency of cells that expressed LANA::βla across multiple tissues and in both immunocompetent and immunodeficient hosts. Strikingly, whereas the cyclin-deficient virus had a reactivation defect in bulk culture, sort purified cyclin-deficient LANA::βla expressing cells were fully capable of reactivation. These data emphasize that the γHV68 latent reservoir is comprised of at least two distinct stages of infection characterized by differential LANA expression, and that a primary function of the viral cyclin is to promote LANA expression during latency, a state associated with ex vivo reactivation competence.

Indexed as

Gene Expression Regulation, ViralVirus ActivationVirus ReplicationAnimalsAntigens, ViralCyclinsGammaherpesvirinaeHerpesviridae InfectionsMiceMice, Inbred C57BLNuclear ProteinsPersistent InfectionViral ProteinsVirus LatencyAntigens, ViralCyclinslatency-associated nuclear antigenNuclear ProteinsViral Proteins

Identifiers

PMID34780571
PMCPMC8629379
OpenAlexW3213589849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.